Jiangsu Key Laboratory of Drug Screening, China Pharmaceutical University, Nanjing, Jiangsu, China.
Jiangsu Center for Pharmacodynamics Research and Evaluation, China Pharmaceutical University, No. 24, Tongjiaxiang, Nanjing, China.
Invest New Drugs. 2020 Apr;38(2):515-524. doi: 10.1007/s10637-020-00894-6. Epub 2020 Feb 1.
E3 ligases are a class of critical enzymes that can catalyse the transfer of ubiquitin (Ub) from an E2 enzyme to the substrate and are essential to cellular processes. The E3 ligase HUWE1 (also known as ARF-BP1, HECTH9, HSPC272, Ib772, LASU1, MULE, URE-B1, UREB1, and HECT, UBA and WWE domain-containing E3 ubiquitin protein ligase 1) is encoded by the huwe1 gene. HUWE1 is a key regulator of the DNA damage response, transcription, autophagy, apoptosis and metabolism in a variety of cancers. Due to its pivotal role in conferring substrate specificity, HUWE1 has attracted enormous attention as a promising anticancer drug target. In this review, we indicate the specific molecular structure of HUWE1 and its role in various cellular signalling pathways and highlight new insights into HUWE1 in cancer. Finally, we discuss outstanding questions regarding HUWE1 in oncology and highlight its limitations in drug development and clinical guidance to better define the role of HUWE1 in multiple cancers.
E3 连接酶是一类关键酶,能够催化泛素(Ub)从 E2 酶转移到底物上,对于细胞过程至关重要。E3 连接酶 HUWE1(也称为 ARF-BP1、HECTH9、HSPC272、Ib772、LASU1、MULE、URE-B1、UREB1 和 HECT、UBA 和 WWE 结构域包含 E3 泛素蛋白连接酶 1)由 huwe1 基因编码。HUWE1 是多种癌症中 DNA 损伤反应、转录、自噬、细胞凋亡和代谢的关键调节剂。由于其在赋予底物特异性方面的关键作用,HUWE1 作为一种有前途的抗癌药物靶点引起了极大的关注。在这篇综述中,我们指出了 HUWE1 的特定分子结构及其在各种细胞信号通路中的作用,并强调了癌症中 HUWE1 的新见解。最后,我们讨论了肿瘤学中关于 HUWE1 的悬而未决的问题,并强调了其在药物开发和临床指导方面的局限性,以更好地定义 HUWE1 在多种癌症中的作用。